Common Contracts
4 similar Sales Agreement contracts by PDS Biotechnology Corp, Perspective Therapeutics, Inc., PLBY Group, Inc., Sonim Technologies Inc
PDS BIOTECHNOLOGY CORPORATION Common Stock (par value $0.00033 per share) Amended and Restated At Market Issuance Sales AgreementSales Agreement • August 13th, 2024 • PDS Biotechnology Corp • Pharmaceutical preparations • New York
Perspective Therapeutics, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • August 13th, 2024 • Perspective Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
Perspective Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. and RBC Capital Markets, LLC (each, an “Agent” and together, the “Agents”), as follows:
PLBY GROUP, INC. Common Stock ($0.0001 par value per share) Sales AgreementSales Agreement • August 8th, 2024 • PLBY Group, Inc. • Retail-miscellaneous retail • New York
PLBY Group, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Roth Capital Partners, LLC (the “Agent”), as follows:
SONIM TECHNOLOGIES, INC. Common Stock ($0.001 par value per share) Sales AgreementSales Agreement • August 7th, 2024 • Sonim Technologies Inc • Telephone & telegraph apparatus • New York
Sonim Technologies, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Roth Capital Partners, LLC (the “Agent”), as follows:
